Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 205003
Company: ADHERA
Company: ADHERA
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
PRESTALIA | AMLODIPINE BESYLATE; PERINDOPRIL ARGININE | EQ 2.5MG BASE;3.5MG | TABLET;ORAL | Prescription | None | Yes | No |
PRESTALIA | AMLODIPINE BESYLATE; PERINDOPRIL ARGININE | EQ 5MG BASE;7MG | TABLET;ORAL | Prescription | None | Yes | No |
PRESTALIA | AMLODIPINE BESYLATE; PERINDOPRIL ARGININE | EQ 10MG BASE;14MG | TABLET;ORAL | Prescription | None | Yes | Yes |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
01/21/2015 | ORIG-1 | Approval | Type 4 - New Combination | STANDARD |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205003s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/205003Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/205003Orig1s000TOC.cfm |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
09/29/2017 | SUPPL-3 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205003s003lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/205003Orig1s003ltr.pdf | |
11/23/2016 | SUPPL-2 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/205003Ss002lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/205003Orig1s002ltr.pdf | |
08/25/2015 | SUPPL-1 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205003s001lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/205003Orig1s001ltr.pdf |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
09/29/2017 | SUPPL-3 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205003s003lbl.pdf | |
11/23/2016 | SUPPL-2 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/205003Ss002lbl.pdf | |
08/25/2015 | SUPPL-1 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205003s001lbl.pdf | |
01/21/2015 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205003s000lbl.pdf |